$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000072312514000013 Filed on January 07, 2014

Income Statement

Concept	2013 Q4	2012 Q4
Revenue	$4.042B	$1.834B
YoY Change	120.39%	-12.25%
Cost Of Revenue	$2.761B	$1.617B
YoY Change	70.75%	-9.41%
Gross Profit	$1.281B	$217.0M
YoY Change	490.32%	-28.85%
Gross Profit Margin	31.69%	11.83%
Selling, General & Admin	$176.0M	$119.0M
YoY Change	47.9%	-21.19%
% of Gross Profit	13.74%	54.84%
Research & Development	$320.0M	$224.0M
YoY Change	42.86%	-2.61%
% of Gross Profit	24.98%	103.23%
Depreciation & Amortization	$468.0M	$457.0M
YoY Change	2.41%	-18.97%
% of Gross Profit	36.53%	210.6%
Operating Expenses	$496.0M	$343.0M
YoY Change	44.61%	-9.97%
Operating Profit	$551.0M	-$97.00M
YoY Change	-668.04%	36.62%
Interest Expense	$101.0M	$57.00M
YoY Change	77.19%	62.86%
% of Operating Profit	18.33%
Other Income/Expense, Net	-$80.00M	-$59.00M
YoY Change	35.59%
Pretax Income	$375.0M	-$210.0M
YoY Change	-278.57%	82.61%
Income Tax	$80.00M	$13.00M
% Of Pretax Income	21.33%
Net Earnings	$358.0M	-$275.0M
YoY Change	-230.18%	47.06%
Net Earnings / Revenue	8.86%	-14.99%
Basic Earnings Per Share	$0.34	-$0.27
Diluted Earnings Per Share	$0.30	-$0.27
COMMON SHARES
Basic Shares Outstanding	1.046B shares	1.014B shares
Diluted Shares Outstanding	1.196B shares	1.014B shares

Balance Sheet

Concept	2013 Q4	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.870B	$2.271B
YoY Change	70.41%	18.59%
Cash & Equivalents	$3.654B	$2.102B
Short-Term Investments	$216.0M	$169.0M
Other Short-Term Assets	$207.0M	$74.00M
YoY Change	179.73%	-22.92%
Inventory	$2.459B	$1.831B
Prepaid Expenses
Receivables	$2.533B	$863.0M
Other Receivables	$300.0M	$224.0M
Total Short-Term Assets	$9.369B	$5.315B
YoY Change	76.27%	-3.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.733B	$7.199B
YoY Change	7.42%	-3.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$490.0M	$343.0M
YoY Change	42.86%	-13.6%
Other Assets	$494.0M	$324.0M
YoY Change	52.47%	-28.0%
Total Long-Term Assets	$10.43B	$8.752B
YoY Change	19.12%	0.37%
TOTAL ASSETS
Total Short-Term Assets	$9.369B	$5.315B
Total Long-Term Assets	$10.43B	$8.752B
Total Assets	$19.79B	$14.07B
YoY Change	40.71%	-1.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.164B	$825.0M
YoY Change	41.09%	0.86%
Accrued Expenses	$337.0M	$458.0M
YoY Change	-26.42%	10.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.543B	$266.0M
YoY Change	480.08%	82.19%
Total Short-Term Liabilities	$4.513B	$2.138B
YoY Change	111.09%	5.79%
LONG-TERM LIABILITIES
Long-Term Debt	$4.260B	$3.169B
YoY Change	34.43%	60.62%
Other Long-Term Liabilities	$875.0M	$574.0M
YoY Change	52.44%	12.99%
Total Long-Term Liabilities	$875.0M	$3.743B
YoY Change	-76.62%	50.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.513B	$2.138B
Total Long-Term Liabilities	$875.0M	$3.743B
Total Liabilities	$9.648B	$5.881B
YoY Change	64.05%	30.63%
SHAREHOLDERS EQUITY
Retained Earnings	$126.0M	-$1.677B
YoY Change	-107.51%	201.08%
Common Stock	$9.025B	$9.063B
YoY Change	-0.42%	3.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.219B	$7.469B
YoY Change
Total Liabilities & Shareholders Equity	$19.79B	$14.07B
YoY Change	40.71%	-1.01%

Cashflow Statement

Concept	2013 Q4	2012 Q4
OPERATING ACTIVITIES
Net Income	$358.0M	-$275.0M
YoY Change	-230.18%	47.06%
Depreciation, Depletion And Amortization	$468.0M	$457.0M
YoY Change	2.41%	-18.97%
Cash From Operating Activities	$1.507B	$236.0M
YoY Change	538.56%	-41.58%
INVESTING ACTIVITIES
Capital Expenditures	$669.0M	$434.0M
YoY Change	54.15%	-37.73%
Acquisitions
YoY Change
Other Investing Activities	-$29.00M	-$3.000M
YoY Change	866.67%	-111.54%
Cash From Investing Activities	-$122.0M	-$639.0M
YoY Change	-80.91%	-10.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$42.00M	$2.000M
YoY Change	2000.0%
Debt Paid & Issued, Net		$52.00M
YoY Change		8.33%
Cash From Financing Activities	-592.0M	$46.00M
YoY Change	-1386.96%	-29.23%
NET CHANGE
Cash From Operating Activities	1.507B	$236.0M
Cash From Investing Activities	-122.0M	-$639.0M
Cash From Financing Activities	-592.0M	$46.00M
Net Change In Cash	793.0M	-$357.0M
YoY Change	-322.13%	45.71%
FREE CASH FLOW
Cash From Operating Activities	$1.507B	$236.0M
Capital Expenditures	$669.0M	$434.0M
Free Cash Flow	$838.0M	-$198.0M
YoY Change	-523.23%	-32.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2115000000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2630000000	USD
CY2013Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	290000000	USD
CY2013Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	239000000	USD
CY2013Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	374000000	USD
CY2013Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	605000000	USD
CY2013Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1048000000	USD
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1164000000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2533000000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2069000000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13668000000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13294000000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	68000000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	63000000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8919000000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9187000000	USD
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000	USD
CY2012Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	28000000	USD
CY2013Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	50000000	USD
CY2013Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23000000	USD
CY2012Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20000000	USD
CY2012Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	357000000	shares
CY2013Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38000000	shares
CY2013Q3	us-gaap	Assets Assets	19118000000	USD
CY2013Q4	us-gaap	Assets Assets	19794000000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	8911000000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	9369000000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2986000000	USD
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2283000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2985000000	USD
CY2013Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2283000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	216000000	USD
CY2013Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	221000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	2979000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	771000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	771000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	1677000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1677000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2980000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	113000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	93000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	538000000	USD
CY2013Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	499000000	USD
CY2012Q4	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.23
CY2012Q4	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.23
CY2012Q4	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-226000000	USD
CY2012Q4	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2619000000	USD
CY2013Q3	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	168000000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	2601000000	USD
CY2013Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	80000000	USD
CY2012Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	59000000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2880000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3654000000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2102000000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2459000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	774000000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-357000000	USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1044000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1058000000	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1044000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1058000000	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	106000000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	104000000	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-272000000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	363000000	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	23000000	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-272000000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	386000000	USD
CY2012Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1617000000	USD
CY2013Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2761000000	USD
CY2013Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	140000000	USD
CY2013Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	192000000	USD
CY2013Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	5803000000	USD
CY2013Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6037000000	USD
CY2012Q4	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2013Q4	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	756000000	USD
CY2013Q4	us-gaap	Debt Current DebtCurrent	1543000000	USD
CY2013Q3	us-gaap	Debt Current DebtCurrent	1585000000	USD
CY2013Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	73000000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	243000000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	236000000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	861000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	802000000	USD
CY2013Q4	us-gaap	Depreciation Depreciation	468000000	USD
CY2012Q4	us-gaap	Depreciation Depreciation	437000000	USD
CY2013Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-14000000	USD
CY2012Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-51000000	USD
CY2013Q4	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on our financial statements.</font></div></div>
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2013Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-19000000	USD
CY2012Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	337000000	USD
CY2013Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	267000000	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	166000000	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M
CY2013Q4	us-gaap	Equity Method Investments EquityMethodInvestments	490000000	USD
CY2013Q3	us-gaap	Equity Method Investments EquityMethodInvestments	396000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	406000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	383000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	90000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	45000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	56000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	66000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	74000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	774000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	769000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	386000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	368000000	USD
CY2013Q4	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our first quarters of fiscal 2014 and 2013 ended on November 28, 2013 and November 29, 2012, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 29, 2013.</font></div></div>
CY2013Q4	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	6000000	USD
CY2013Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000000	USD
CY2012Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59000000	USD
CY2013Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8000000	USD
CY2012Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	5000000	USD
CY2012Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2013Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-233000000	USD
CY2013Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-75000000	USD
CY2012Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2013Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-86000000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	217000000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	1281000000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	375000000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-210000000	USD
CY2013Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	86000000	USD
CY2012Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-52000000	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80000000	USD
CY2013Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	76000000	USD
CY2012Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	11000000	USD
CY2012Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.01
CY2013Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.06
CY2013Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	65000000	USD
CY2013Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	74000000	USD
CY2013Q4	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	212000000	USD
CY2012Q4	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-36000000	USD
CY2012Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4000000	USD
CY2013Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-59000000	USD
CY2013Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-190000000	USD
CY2012Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26000000	USD
CY2012Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-108000000	USD
CY2013Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	408000000	USD
CY2013Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-182000000	USD
CY2012Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6000000	USD
CY2013Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	494000000	USD
CY2012Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-98000000	USD
CY2012Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2013Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-556000000	USD
CY2012Q4	us-gaap	Interest Expense InterestExpense	57000000	USD
CY2013Q4	us-gaap	Interest Expense InterestExpense	101000000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	836000000	USD
CY2013Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	796000000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	2459000000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	2649000000	USD
CY2013Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	134000000	USD
CY2013Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	161000000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1462000000	USD
CY2013Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1719000000	USD
CY2012Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
CY2013Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	9648000000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	9112000000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19118000000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19794000000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4125000000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4513000000	USD
CY2013Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4452000000	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4260000000	USD
CY2013Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Rambus</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2013, subsequent to the end of our first fiscal quarter of 2014, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  We also entered into a 7-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term.  We agreed to pay Rambus up to $10 million per quarter over 7 years, for a total of $280 million.  The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions.  As a result, other operating expense for the quarter ended November 28, 2013 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including Elpida Memory, Inc. and Elpida Memory (USA) Inc. (collectively “Elpida”).  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain Elpida DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. On March 23, 2012, Elpida filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against Elpida. Accordingly, the plaintiffs' case against Elpida is stayed. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2011, the Board of Trustees for the University of Illinois filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board held a hearing in connection with the three petitions on December 9, 2013. A final decision is expected by the end of March 2014. The District Court has stayed the litigation pending the outcome of the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent Office.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. On September 24, 2013, the Court entered an order staying our case pending the resolution of co-pending cases brought by Semcon Tech, LLC against Applied Materials and Ebara Technologies, Inc.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 7, 2007, Tessera, Inc. filed a patent infringement against Elpida Memory, Inc., Elpida Memory (USA) Inc. (collectively "Elpida"), and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain Elpida products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, Elpida and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against Elpida and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by Elpida. Tessera Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. The Eastern District of Texas case currently remains stayed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPSDR, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July, 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Securities Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 12, 2013, seven former shareholders of Elpida Memory, Inc. ("Elpida") filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of Elpida as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of Elpida and deceive shareholders prior to Elpida filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys’ fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Commercial Matters</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against us and Micron Semiconductor B.V., our Netherlands subsidiary, in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between us and Qimonda signed in fall 2008 pursuant to which we purchased all of Qimonda's shares of Inotera Memories, Inc. and seeks an order requiring us to retransfer the Inotera shares purchased from Qimonda to the Qimonda estate. The complaint also seeks to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after a series of hearings with pleadings, arguments and witnesses. The most recent hearing was held on November 12, 2013 and an additional hearing is scheduled in January 2014. We are unable to predict the outcome of this lawsuit and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages and the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition. As of November 28, 2013, the Inotera shares purchased from Qimonda had a carrying value of $241 million and a market value of $814 million.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.</font></div></div>
CY2013Q3	us-gaap	Minority Interest MinorityInterest	864000000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	927000000	USD
CY2013Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
CY2012Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	0	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-735000000	USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	46000000	USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-639000000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	21000000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1507000000	USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	236000000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-275000000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	358000000	USD
CY2012Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2013Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23000000	USD
CY2012Q4	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
CY2013Q4	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	49000000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-97000000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	551000000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	207000000	USD
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	276000000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	494000000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	439000000	USD
CY2012Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	434000000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	2000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-2000000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-5000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000000	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	535000000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	875000000	USD
CY2013Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-80000000	USD
CY2012Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59000000	USD
CY2012Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000000	USD
CY2013Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-237000000	USD
CY2013Q4	us-gaap	Other Receivables OtherReceivables	235000000	USD
CY2013Q3	us-gaap	Other Receivables OtherReceivables	186000000	USD
CY2013Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-25000000	USD
CY2012Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-3000000	USD
CY2013Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42000000	USD
CY2012Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2000000	USD
CY2013Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	196000000	USD
CY2012Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	317000000	USD
CY2013Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	526000000	USD
CY2013Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation.</font></div></div>
CY2012Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	173000000	USD
CY2013Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2013Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	144000000	USD
CY2013Q4	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	49000000	USD
CY2012Q4	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2012Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-19000000	USD
CY2013Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-20000000	USD
CY2013Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	162000000	USD
CY2012Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	109000000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	381000000	USD
CY2012Q4	us-gaap	Profit Loss ProfitLoss	-275000000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21401000000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20920000000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7733000000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7626000000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2833000000	USD
CY2013Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	2329000000	USD
CY2013Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	737000000	USD
CY2012Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	52000000	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320000000	USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	224000000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	556000000	USD
CY2012Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-22000000	USD
CY2013Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-8000000	USD
CY2013Q3	us-gaap	Restructuring Reserve RestructuringReserve	12000000	USD
CY2013Q4	us-gaap	Restructuring Reserve RestructuringReserve	1000000	USD
CY2012Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-21000000	USD
CY2013Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-3000000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-212000000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	126000000	USD
CY2012Q4	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	26000000	USD
CY2013Q4	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	14000000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	4042000000	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1834000000	USD
CY2013Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176000000	USD
CY2012Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	119000000	USD
CY2012Q4	us-gaap	Share Based Compensation ShareBasedCompensation	19000000	USD
CY2013Q4	us-gaap	Share Based Compensation ShareBasedCompensation	22000000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.31
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.73
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10000000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.013	pure
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.62	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.50	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	140000000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	73000000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.99
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.58
CY2013Q4	us-gaap	Share Price SharePrice	21.17
CY2013Q3	us-gaap	Share Price SharePrice	13.57
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y0M
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	9219000000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	9142000000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10146000000	USD
CY2013Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10006000000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8186000000	USD
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8417000000	USD
CY2013Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	286000000	USD
CY2012Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	-41000000	USD
CY2013Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	47000000	USD
CY2013Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	42000000	USD
CY2012Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	150000000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1196000000	shares
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1014000000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1046000000	shares
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1014000000	shares
CY2013Q4	mu	Available For Sale Securities Debt Maturities After Four Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsAmortizedCost	12000000	USD
CY2013Q4	mu	Available For Sale Securities Debt Maturities After Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsFairValue	12000000	USD
CY2013Q4	mu	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	257000000	USD
CY2013Q4	mu	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	258000000	USD
CY2013Q4	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsAmortizedCost	262000000	USD
CY2013Q4	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsFairValue	262000000	USD
CY2013Q4	mu	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	1000000	USD
CY2013Q3	mu	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	1000000	USD
CY2013Q4	mu	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	0	USD
CY2013Q3	mu	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1000000	USD
CY2012Q4	mu	Business Acquisition Pro Forma Net Income Loss Attributable To Parent BusinessAcquisitionProFormaNetIncomeLossAttributableToParent	-237000000	USD
CY2013Q4	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	491000000	USD
CY2012Q4	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	457000000	USD
CY2013Q4	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	104000000	USD
CY2013Q3	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	182000000	USD
CY2013Q4	mu	Option Indexed To Issuers Equity Settlement Cash Received OptionIndexedToIssuersEquitySettlementCashReceived	0	USD
CY2012Q4	mu	Option Indexed To Issuers Equity Settlement Cash Received OptionIndexedToIssuersEquitySettlementCashReceived	24000000	USD
CY2013Q4	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	1000000	USD
CY2012Q4	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	0	USD
CY2013Q4	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	4000000	USD
CY2012Q4	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	3000000	USD
CY2012Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	104000000	USD
CY2013Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	143000000	USD
CY2013Q4	mu	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Subject To Outstanding Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesSubjectToOutstandingAwards	67000000	shares
CY2013Q4	dei	Amendment Flag AmendmentFlag	false
CY2013Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-28
CY2013Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2013Q4	dei	Document Period End Date DocumentPeriodEndDate	2013-11-28
CY2013Q4	dei	Document Type DocumentType	10-Q
CY2013Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1060879576	shares
CY2013Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q4	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC

Files In Submission

Name	View Source	Status
0000723125-14-000013-index-headers.html	Edgar Link	pending
0000723125-14-000013-index.html	Edgar Link	pending
0000723125-14-000013.txt	Edgar Link	pending
0000723125-14-000013-xbrl.zip	Edgar Link	pending
a2014q1.htm	Edgar Link	pending
a2014q1ex31-1ceocert.htm	Edgar Link	pending
a2014q1ex31-2cfocert.htm	Edgar Link	pending
a2014q1ex32-1906ceocert.htm	Edgar Link	pending
a2014q1ex32-2906cfocert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mu-20131128.xml	Edgar Link	completed
mu-20131128.xsd	Edgar Link	pending
mu-20131128_cal.xml	Edgar Link	unprocessable
mu-20131128_def.xml	Edgar Link	unprocessable
mu-20131128_lab.xml	Edgar Link	unprocessable
mu-20131128_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2013 Q4 Form 10-Q Financial Statement

#000072312514000013 Filed on January 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2013 Q4 Form 10-Q Financial Statement

#000072312514000013 Filed on January 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu